[EN] 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS<br/>[FR] INHIBITEURS DE LA PHOSPHOLIPASE ASSOCIÉE AUX LIPOPROTÉINES A2 (LP-PLA2) À BASE DE 2,3-DIHYDRO-IMIDAZOL[1,2-C]PYRIMIDIN-5(1 H)-ONE
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2014114694A1
公开(公告)日:2014-07-31
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
本发明涉及抑制Lp-PLA2活性的新化合物,以及其制备方法、含有它们的组合物,以及它们在治疗与Lp-PLA2活性相关的疾病中的应用,例如动脉粥样硬化、阿尔茨海默病。